Navigation Links
Meet TerViva, an Emerging Star in Sustainable Biofuels
Date:11/22/2013

New York, NY (PRWEB) November 22, 2013

TerViva, a start-up based in Oakland, California, is changing the face of agriculture and aims to diversify and sustain the world’s agriculture one crop at a time. Working within the $121B biofuels market, TerViva is taking its first stab at commercial-level agriculture with its new legume crop, Pongamia.

Pongamia is a hardy plant that is able to withstand harsh conditions such as soil salinity and low water levels, which would be impossible for other plants. With 20 times as many gallons per acre than corn, Pongamia can drop-in to existing agricultural infrastructure and provides biofuel and protein-rich seedcake that may be used for animal feed. Not to mention, Pongamia grows on land that does not compete for food.

As the world’s food and supply demand increases while farmland is reduced, a solution for land deemed “unusable farmland” must be found. TerViva is well on its way to doing just that. The key to sustainable agriculture is bringing more biodiversity to already existing infrastructure, according to TerViva. With just 7 crops dominating the U.S. agriculture scene, TerViva wants to encourage a variety of species.

Working with some big partners, including US Sugar Corp and Mosaic, some of ag’s biggest leaders are firm believers of TerViva’s work and potential. Just recently, TerViva signed with one of the largest agriculture operators in the country to produce Pongamia on 10,000 acres.

And with TerViva’s team credentials, it’s no wonder they’re grabbing the attention of some of the largest ag companies in the U.S. TerViva’s cofounders and investors include Joseph Andrew, former Chairman of the Democratic National Party, his wife Ann Slaughter Andrew an environmental attorney and the former Ambassador to Costa Rica, and CEO Naveen Sikka who served on the steering committee for Cleantech for Obama. TerViva has also been featured in numerous biofuels trade publications, and more recently featured in CNN Money and VentureBeat.

If you’d like to know more about TerViva, tune into Monday’s live webinar hosted by AgFunder, the worlds leading investment crowd-funding platform for agriculture and agtech. The webinar will be on Monday, September 25th at 12:30-1:30 (ET). The webinar will be focused on TerViva’s efforts, as well as AgFunder’s Fund for TerViva as they aim to raise $500,000 for AgFunder’s TerViva Fund I. Investors interested in viewing the webinar can register at: http://www.agfunder.com/webinar/terviva.

In an effort to change the face of agriculture and diversify crops for sustainability, TerViva invites you to join the conversation.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11361421.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genelux, a Leader in the Emerging Oncolytic Virotherapy Field, Receives Significant Industry Honor from Elsevier Business Intelligence, Identifying GL-ONC1 as One of 2013s Top Oncology Projects to Watch
2. PAREXEL International To Present At Goldman Sachs Emerging Growth Conference
3. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
4. Market Briefing: Emerging Growth NASDAQ Stocks in the News
5. Interventional Cardiology Devices - Emerging Markets 2009-2015
6. Green future development: Top 10 priorities for emerging economy countries
7. Emerging Global Leader in Emergency Thermotherapy for Traumatic Brain Injury Expands US Operations to Site on the Campus of New York Medical College
8. Next Generation Sequencing: Emerging Clinical Applications and Global Markets
9. Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
10. PrimeraDx Featured in the Goldman Sachs Healthcare Research Teams GS Emerging Healthcare Series
11. Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... exhibits both viscous and elastic characteristics when deformed, which is identical to how ... to gently absorb compressive forces and return to its natural state along a ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):